![Loading Events](https://sph.unc.edu/wp-content/plugins/the-events-calendar/src/resources/images/tribe-loading.gif)
![](https://sph.unc.edu/wp-content/uploads/sites/112/2018/10/header-large-mcg-front1.jpg)
Events and Announcements
- This event has passed.
CTSA Visiting Scholar Seminar – Therapeutic Advances in Hereditary Hemorrhagic Telangiectasia
April 8, 2021 @ 12:00 pm - 1:00 pm
Event Navigation
Join translational and clinical scientists from across the CTSA Consortium for a presentation by Hanny Al-Samkari, MD describing the revolutionary potential of anti-angiogenic therapy in hereditary hemorrhagic telangiectasia (HHT) and the evidence to date for systemic bevacizumab as a treatment for bleeding and anemia in HHT.
Contact Allison Rorie with any questions.